T1	Participants 111 144	treatment of Helicobacter pylori.
T2	Participants 213 243	Helicobacter pylori infection.
T3	Participants 483 499	patients with H.
T4	Participants 500 517	pylori infection.
T5	Participants 518 634	Sixty patients with peptic ulcer (gastric, 32 patients; duodenal, 28 patients) who had a history of ulcer recurrence
T6	Participants 925 969	Forty-eight patients completed the protocol;
